Coronaria Oy Announces the Preliminary Amount of Acceptances as of October 17, 2019 and Extends the Subsequent Offer Period of the Public Tender Offer for All Shares Issued by Silmäasema Oyj
Silmäasema Oyj
Stock Exchage Release
18 October 2019 at 3:30 p.m. EEST
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG, OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, SEE SECTION “IMPORTANT INFORMATION” BELOW.
Silmäasema Oyj has received the following information regarding Coronaria’s subsequent offer period of the public tender offer for all shares in Silmäasema Oyj:
Coronaria Oy (“Coronaria” or the “Offeror”) has on September 5, 2019 commenced a mandatory public tender offer to purchase all of the issued and outstanding shares in Silmäasema Oyj (“Silmäasema”) that are not held by the Offeror, Silmäasema or any of its subsidiaries (the “Tender Offer”). The subsequent offer period under the Tender Offer (the “Subsequent Offer Period”) commenced on October 2, 2019 at 9:30 a.m. (Finnish time) and was scheduled to expire on October 17, 2019 at 4:00 p.m. (Finnish time).
The Offeror has decided to extend the Subsequent Offer Period of the Tender Offer by three weeks to end on November 7, 2019 at 4:00 p.m. (Finnish time).
Based on preliminary information the shares tendered during the Subsequent Offer Period as of October 17, 2019 represent approximately 4.4% of all the issued and outstanding shares and votes in Silmäasema. Together with the shares tendered during the initial offer period and otherwise acquired by the Offeror through market purchases the shares represent approximately 88.7% of all the issued and outstanding shares and votes in Silmäasema in aggregate.
Settlement trades for shares that have been tendered during the Subsequent Offer Period are executed every two weeks. The Offeror will confirm and announce the final amount of shares validly tendered during the Subsequent Offer Period up to October 17, 2019 on or about October 22, 2019, and will complete the settlement trades for such shares on or about October 23, 2019.
The Offeror will announce the preliminary number of shares validly tendered during the Subsequent Offer Period up to October 31, 2019 and up to November 7, 2019 on or about the first business day following those dates, and the final amount on or about the third business day following those dates. Settlement trades for such shares will be completed on or about the fourth business day following each of the above mentioned dates in accordance with the terms and conditions of the Tender Offer. The actual time of receipt of the payment by tendering shareholders will depend on the time required to process the onward payment by financial institutions.
During the Subsequent Offer Period, the Tender Offer can be accepted in accordance with the acceptance procedure described in the terms and conditions of the Tender Offer. All acceptances will be binding and cannot be withdrawn. Further instructions can be obtained from Evli Bank Plc by sending email to operations@evli.com.
The Offeror may purchase shares in Silmäasema during or after the Subsequent Offer Period also in public trading on Nasdaq Helsinki Ltd or otherwise outside the Tender Offer.
Silmäasema’s operations will continue as normal and the transaction has no impact on our customers.
SILMÄASEMA OYJ
Jussi Salminen
CEO
For further information, please contact:
CEO Jussi Salminen, tel. +358 40 834 5818
CFO Sari Nordblad, tel. +358 50 552 7247
Niina Streng, Head of Communications and Investor Relations, tel. +358 50 322 5195
Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has nearly 150 stores and 13 eye clinics in Finland as well as nine stores in Estonia. The Silmäasema chain employs over 1,000 eye healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million in 2018 and adjusted EBITDA was EUR 11.8 million.
IMPORTANT INFORMATION
THIS RELEASE MAY NOT BE RELEASED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDI-RECTLY, IN OR INTO, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW.
THIS RELEASE IS NOT A TENDER OFFER DOCUMENT AND AS SUCH DOES NOT CONSTITUTE AN OFFER OR INVI-TATION TO MAKE A SALES OFFER. IN PARTICULAR, THIS RELEASE IS NOT AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES DESCRIBED HEREIN, AND IS NOT AN EXTENSION OF THE TENDER OFFER, IN OR INTO, THE UNITED STATES CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG. INVESTORS SHALL ACCEPT THE TENDER OFFER FOR THE SHARES ONLY ON THE BASIS OF THE INFORMATION PROVIDED IN A TENDER OFFER DOCUMENT. OFFERS WILL NOT BE MADE DIRECTLY OR INDIRECTLY IN ANY JURISDICTION WHERE EITHER AN OFFER OR PARTICIPATION THEREIN IS PROHIBITED BY APPLICABLE LAW OR WHERE ANY TENDER OFFER DOCUMENT OR REGISTRATION OR OTHER REQUIREMENTS WOULD APPLY IN ADDITION TO THOSE UNDERTAKEN IN FINLAND.